Dual down‐regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual down‐regulation of
EGFR
and
ErbB2
by berberine contributes to suppression of migration and invasion of human ovarian cancer cells
Authors
Keywords
-
Journal
ENVIRONMENTAL TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-16
DOI
10.1002/tox.23076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
- (2019) Amaia Eleonora Maennling et al. Cancers
- Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2
- (2018) Yu Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells
- (2018) Sangmin Kim et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells
- (2018) Yisun Jeong et al. Journal of Breast Cancer
- Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment
- (2018) Parham Jabbarzadeh Kaboli et al. PLoS One
- The promotion function of Berberine for osteogenic differentiation of human periodontal ligament stem cells via ERK-FOS pathway mediated by EGFR
- (2018) Jin Liu et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antitumor Effects of Berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 Breast Cancer Cells Using Molecular Modelling and in Vitro Study
- (2018) Parham Jabbarzadeh Kaboli et al. Pharmacological Reports
- Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition
- (2017) Dong Hou et al. Cell Death & Disease
- Berberine and cinnamaldehyde together prevent lung carcinogenesis
- (2017) Mingjing Meng et al. Oncotarget
- FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition
- (2017) Min Ye et al. Oncotarget
- In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non-water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
- (2016) Tarik Ghadban et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer
- (2016) Junxiong Wang et al. Oncotarget
- Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
- (2014) Parham Jabbarzadeh Kaboli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR-MEK-ERK Signaling Pathway
- (2014) Q. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells
- (2013) Lihong Wang et al. PLoS One
- Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
- (2012) R. Nahta CURRENT MEDICINAL CHEMISTRY
- Berberine, an Isoquinoline Alkaloid, Inhibits the Metastatic Potential of Breast Cancer Cells via Akt Pathway Modulation
- (2012) Han-Peng Kuo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
- (2011) Q Sheng et al. BRITISH JOURNAL OF CANCER
- Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells
- (2011) Tzu-Chao Chuang et al. CANCER LETTERS
- Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway
- (2011) Han-Peng Kuo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling
- (2011) Yong Pil Hwang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Blockade of Her2/neuBinding to Hsp90 by Emodin Azide Methyl Anthraquinone Derivative Induces Proteasomal Degradation of Her2/neu
- (2011) Yan-yan Yan et al. MOLECULAR PHARMACEUTICS
- A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
- (2009) Yiyi Sun et al. ANTI-CANCER DRUGS
- Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo
- (2009) Shih-Chung Hsu et al. CANCER LETTERS
- Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
- (2009) Doris R. Siwak et al. Journal of Oncology
- Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer
- (2008) Jacqueline M. Lafky et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The ErbB kinase domain: Structural perspectives into kinase activation and inhibition
- (2008) Ron Bose et al. EXPERIMENTAL CELL RESEARCH
- Berberine Suppresses TNF-α-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells
- (2008) Sangmin Kim et al. MOLECULES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search